Key result
TAVI expands across all surgical risk categories, though conduction and leak complications remain.
Why the study?
More than 20 years after the first TAVI, the technique has evolved with expanded indications across risk categories and decreased complications, warranting a review of patient evaluation, procedural changes, and current challenges.
TAVI has transformed the management of aortic stenosis across surgical risk profiles over the last two decades, though considerations around long-term durability and specific complications continue to guide patient selection.
Answers are grounded in this paper and cite their sources.
Broadens TAVI eligibility across risks; extends 20-year evidence while leaving complication mitigation unresolved.
It has been more than 20 years since the first in man transcatheter aortic valve intervention (TAVI), and during this period we have witnessed an impressive evolution of this technique, with an extension of its use from non-operable patients to high-, intermediate- and even low-risk patients with aortic stenosis, and with a decrease in the incidence of complications. In this review, we discuss the evaluation of patients before TAVI, the procedure and the changes it has seen over time, and we present the current main complications and challenges of TAVI.
No takes yet. Share an insight, caveat, or question.
Postolache et al. (2023) conducted a review in Aortic stenosis. Transcatheter aortic valve intervention (TAVI) vs. Surgical aortic valve replacement (SAVR) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: